RFPL1
Basic information
Region (hg38): 22:29438583-29442455
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RFPL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 0 |
Variants in RFPL1
This is a list of pathogenic ClinVar variants found in the RFPL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-29438916-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
22-29438943-T-G | not specified | Uncertain significance (Mar 28, 2022) | ||
22-29438958-G-A | not specified | Uncertain significance (May 23, 2023) | ||
22-29438982-T-A | not specified | Uncertain significance (Sep 10, 2024) | ||
22-29438984-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
22-29439020-C-A | not specified | Uncertain significance (Nov 28, 2023) | ||
22-29439051-A-G | not specified | Uncertain significance (Mar 15, 2024) | ||
22-29439082-G-C | not specified | Uncertain significance (Sep 08, 2024) | ||
22-29439143-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
22-29441551-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
22-29441580-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
22-29441619-T-C | not specified | Uncertain significance (Nov 13, 2024) | ||
22-29441620-G-T | not specified | Uncertain significance (Nov 13, 2024) | ||
22-29441634-C-T | not specified | Likely benign (Nov 27, 2024) | ||
22-29441650-A-C | not specified | Uncertain significance (Mar 01, 2024) | ||
22-29441667-A-G | not specified | Uncertain significance (Mar 18, 2024) | ||
22-29441703-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
22-29441704-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
22-29441805-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
22-29441806-G-A | not specified | Uncertain significance (Dec 16, 2021) | ||
22-29441820-G-A | not specified | Uncertain significance (May 05, 2023) | ||
22-29441841-C-T | not specified | Uncertain significance (Jul 23, 2024) | ||
22-29441890-A-C | not specified | Uncertain significance (Jan 03, 2024) | ||
22-29442006-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
22-29442015-T-C | not specified | Likely benign (Dec 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RFPL1 | protein_coding | protein_coding | ENST00000354373 | 2 | 3873 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0124 | 0.667 | 125738 | 0 | 9 | 125747 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.409 | 167 | 183 | 0.915 | 0.0000105 | 2086 |
Missense in Polyphen | 40 | 48.734 | 0.82077 | 643 | ||
Synonymous | -1.47 | 88 | 72.2 | 1.22 | 0.00000431 | 638 |
Loss of Function | 0.515 | 3 | 4.13 | 0.726 | 1.77e-7 | 58 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000124 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000441 | 0.0000439 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates the G2-M phase transition, possibly by promoting cyclin B1/CCNB1 and CDK1 proteasomal degradation and thereby preventing their accumulation during interphase. {ECO:0000269|PubMed:20725088}.;
Intolerance Scores
- loftool
- 0.915
- rvis_EVS
- 1.4
- rvis_percentile_EVS
- 94.7
Haploinsufficiency Scores
- pHI
- 0.0982
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.418
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0503
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- cell cycle;negative regulation of cell population proliferation;negative regulation of G2/M transition of mitotic cell cycle;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;negative regulation of cell division;positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis
- Cellular component
- nucleus;cytoplasm
- Molecular function
- metal ion binding